Adult living donor versus deceased donor liver transplantation: A 6-year single center experience

American Journal of Transplantation

Volumn 5, Issue 1, 2005, Pages 149-156

  Maluf, Daniel G ^a   Stravitz, Richard Todd ^b   Cotterell, Adrian H ^a   Posner, Marc P ^a   Nakatsuka, Mitsuru ^b   Sterling, Richard K ^b   Luketic, Velimir A ^b   Shiffman, Mitchell L ^b   Ham, John M ^c   Marcos, Amadeo ^d   Behnke, Martha K ^a   Fisher, Robert A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Acute rejection; Adult deceased donor; Adult living donor; Biliary complications; HCV recurrence

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; BILIARY TRACT DISEASE; CADAVER DONOR; CHRONIC GRAFT REJECTION; COMPARATIVE STUDY; FEMALE; HEALTH CARE COST; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; SCORING SYSTEM; SURVIVAL;

ADULT; AGED; BIOPSY; CADAVER; COLD; FEMALE; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISCHEMIA; LIVER; LIVER DISEASES; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 19944428273     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00654.x     Document Type: Article

References (27)

1. Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 1990; 212: 368-377.
2. Ryckman FC, Flake AW, Fisher RA, Tchervenkov JI, Pedersen SH, Balistreri WF. Segmental orthotopic liver transplantation as a means to improve patient survival and diminish waiting-list mortality. J Pediatr Surg 1991; 26: 422-428.
3. Broelsch CE, Malago M, Testa G, Valentin Gamazo C. Living donor liver transplantation in adults: Outcome in Europe. Liver Transpl 2000; 6 (Suppl 2): S64-S65.
4. Todo S, Furukawa H, Jin MB, Shimamura T. Living donor liver transplantation in adults: Outcome in Japan. Liver Transpl 2000; 6 (Suppl 2): S66-S72.
5. Marcos A. Right-lobe living donor liver transplantation. Liver Transpl 2000; 6 (Suppl 2): S59-S63.
6. Marcos A, Fisher RA, Ham JM et al. Right lobe living donor liver transplantation. Transplantation 1999; 68: 798-803.
7. Marcos A, Ham JM, Fisher RA, Olzinski AT, Posner MP. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl 2000; 6: 296-301.
8. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
9. Trotter JF, Wachs, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002; 346: 1074-1082.
10. Fisher RA, Ham JM, Marcos A et al. A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation. Transplantation 1998; 66: 1616-1621.
11. Shiffman ML, Fisher RA, Stravitz RT et al. Histologic analysis of recurrent hepatitis C virus infection following living donor and cadaveric liver transplantation [Abstract]. Am J Transplant 2003; 3 (Suppl 5): 203.
12. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997; 25: 658-663.
13. Cotterell AH, Fisher RA, Dawson S et al. Right lobe living donor liver transplant update-3 year follow up of donors [Abstract 225]. Transplantation 2002; 74: 87.
14. Cotterell AH, Fisher RA, Wolf LG et al. Comparison of Rouxen-Y versus duct to duct biliary reconstruction in adult-to-adult living donor right lobe liver transplantation [Abstract 33]. Am J Transplant 2003; 3 (Suppl 5): 160.
15. Marcos A, Fisher RA, Ham JM et al. Emergency portacaval shunt for the control of hemorage from a parenchymal fracture after adult-to-adult living donor liver transplantation. Transplantation 2000; 26: 2218-2221.
16. Axelrod DA, Guidinger MK, McCullough KP, Leichtman AB, Punch JD, Merion RM. Association of center volume with outcome after liver and kidney transplantation. Am J Transplant 2004; 4: 920-927.
17. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation [Abstract 544]. Am J Transplant 2004; 4 (Suppl 8): 308.
18. Taniguchi M, Jin MB, Shimamura T, Suzuki T, Furukawa H, Todo S. Predict factor for recipients's recovery after living donor liver transplantation [Abstract 43]. Am J Transplant 2004; 4 (Suppl 8): 171.
19. Fan S, Zhang Z. Comparison of acute cellular rejection between living donor liver transplantation and cadaveric liver transplantation. Zhonghua Yi Xue Za Zhi 2001; 81: 1092-1094.
20. Ghobrial RM, Amersi F, Farmer DG et al. Rapid and severe early HCV recurrence following adult living donor liver transplantation [Abstract 228]. Transplantation 2002; 74(4 Suppl): 88.
21. Taniguchi M, Trotter J, Wachs M et al. Feature of hepatitis C recurrence in living donor liver transplant recipients [Abstract 229]. Transplantation 2002; 74(4 Suppl): 88.
22. Van Vlierberghe H, Troisi R, Colle I, Ricciardi S, Praet M, de Hemptinne B. Hepatitis C infection-related liver disease: Patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults. Transplantation 2004; 77: 210-214.
23. Gaglio PJ, Malireddy S, Levin BS et al. Increase risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transplant 2003; 9: 1028-1035.
24. Russo MW, Galanko J, Beavers K, Fried MN, Shrestha R. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transplant 2004; 10: 347-349.
25. Neumann UP, Berg T, Bahra M et al. Long-term outcome of liver transplants for chronic hepatitis C: A 10 year follow up. Transplantation 2004; 77: 226-231.
26. Kam I. Adult-to-adult right hepatic lobe living donor liver transplantation for status 2a patients: Too little, too late. Liver Transplant 2002; 8: 347-349.
27. Beavers KL, Cassara JE, Shrestha R. Practice patterns for long-term follow-up of adult-to-adult right lobectomy donors at US transplantation centers. Liver Transplant 2003; 9: 645-648.